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The safety and feasibility of laparoscopic gastrectomy (LG) for patients who have undergone previous upper abdominal 
surgery (PUAS) remain unclear. A matched-pair analysis was conducted to compare the short-term outcomes of LG 
between patients with gastric cancer who had undergone PUAS and those who had not. 
Methods 
A matched-pair analysis was performed to compare the short-term outcomes of LG between 22 patients who had 
undergone PUAS and 66 who had not (control group). To compare the outcome to that of open gastrectomy (OG) 
following PUAS, a total of 143 consecutive OG patients treated during the same study period were also reviewed. 
Results 
Cholecystectomy was the most common type of PUAS, followed by gastrectomy. There were no significant differences 
between the groups in terms of the length of the operation, blood loss, the number of retrieved lymph nodes or the rate 
of conversion to open surgery. The postoperative morbidity in the PUAS group (3/22, 13.6%) was comparable to that of 
the control group (7/66, 10.6%, p=0.6981). There was no mortality within 30 days in either group. When compared to 
OG following PUAS (n=23), LG was performed with significantly less blood loss with an equivalent postoperative 
outcome. 
Conclusions 
LG following PUAS is considered to be a safe and feasible surgical modality. PUAS should therefore not be regarded 
as a contraindication for LG. 
 





Gastric cancer is one of the most common malignancies in the world, and it is especially common in East Asia [1]. 
Despite considerable progress in chemotherapy and radiotherapy, gastrectomy combined with adequate lymph node 
dissection remains the gold standard for resectable gastric cancer in East Asia [2], as well as in some Western countries 
[3]. The development of improved techniques for general laparoscopic surgery, coupled with refinements in 
instrumentation, has made laparoscopic gastrectomy (LG) an important treatment option in some specialized centers [4]. 
Recently, a prospective, moderate-sized randomized trial of LG for early gastric cancer reported the non-inferiority of 
LG to open gastrectomy (OG) [5]. Large retrospective studies have also shown acceptable oncologic outcomes [6-8].  
 As the popularity of laparoscopic surgery increases, many patients who have undergone previous upper 
abdominal surgery (PUAS) are considered candidates for LG. PUAS may be associated with difficulty in initial trocar 
placement and obtaining adequate exposure of the operating field. PUAS might also increase the risk of injuring organs 
adherent to the abdominal wall during trocar insertion, as well as adhesiolysis. The feasibility of LG in such patients 
thus remains unclear. A Japanese prospective phase II trial of LG for early gastric cancer (JCOG 0703) has recently 
reported the safety of LG in terms of the incidence of anastomotic leakage or pancreatic fistula formation [4]. However, 
the protocol of that trial excluded patients who had a history of open surgery. It is important to assess the feasibility of 
LG in such patients, although their relatively small (albeit increasing) number would preclude adequate-sized 
prospective clinical trials. We therefore conducted a matched-pair analysis to compare the short-term outcomes of LG 
between patients with gastric cancer who had undergone PUAS and those who had not. This study design was selected 
to minimize the effects of potential confounders, such as age, clinical TNM stage, surgical procedure and body mass 
index (BMI), while maintaining a reasonable sample size. 
 
Methods 
Between August 2005 and December 2010, a total of 281 consecutive patients who underwent LG for histologically 
proven adenocarcinoma of the stomach were reviewed from a prospective database, and clinical data were extracted for 
the analyses. From this cohort, a matched-pair analysis was conducted for all 22 patients who had undergone a PUAS 
(LG-PUAS). Each patient in the PUAS group was matched to three corresponding patients (control) from the remaining 
259 patients with no history of upper abdominal surgery. The LG-PUAS group and control group were matched for age, 
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clinical stage, BMI and type of gastrectomy. Five types of gastrectomy (distal gastrectomy, pylorus-preserving 
gastrectomy, total gastrectomy, proximal gastrectomy and completion gastrectomy for remnant gastric cancer) were 
performed. To simplify the analysis, patients who had undergone pylorus-preserving gastrectomy were combined with 
those who had undergone distal gastrectomy, and the patients who had undergone proximal gastrectomy or completion 
gastrectomy were combined with those who had undergone total gastrectomy on the basis of the area of the operation 
(i.e., whether the esophagus was divided or not). No patient in this cohort had undergone wedge resection with either 
minimal or no lymphadenectomy. To compare the outcomes to those of OG for patients with a history of PUAS 
(OG-PUAS), a total of 143 consecutive patients treated by OG during the same period was also reviewed. 
The clinical stage was classified according to the TNM classification [9]. Upper abdominal surgery was 
defined as any open abdominal operation in which the upper edge of the incision was located as high as the midpoint 
between the xiphoid process and umbilicus or higher. Upper abdominal surgery included laparoscopic procedures that 
involved any intra-abdominal organ higher than the umbilicus (i.e., esophagus, stomach, duodenum, 
hepato-biliary-pancreatic system, spleen, small bowel, ascending to descending colon, kidney and adrenal gland). 
Appendectomy was not included as an upper abdominal surgery. 
 Before April 2009, LG was performed in patients with T3(SS)N0 or earlier disease. Subsequently, the 
indication range of LG was extended to patients with more advanced diseases. As for PUAS, our indications for LG 
were gradually extended in accordance with the characteristics of individual patients. At present, patients who have 
undergone PUAS two or more times and those who have undergone major procedures, such as liver transplantation and 
coronary bypass grafting using the gastroepiploic artery, proceed to OG. All procedures were performed by board 
certified surgeons from the Japan Surgical Society and were controlled by surgeons accredited by the Endoscopic 
Surgical Skill Qualification System from the Japan Society for Endoscopic Surgery [10] or equivalent surgeons. Our 
surgical procedure for LG has been described previously [11]. Briefly, the patient is placed in a modified lithotomy 
position in a reverse Trendelenburg fashion. The first port is inserted transumbilically by the open method. This can be 
done relatively easily even in patients who have had previous laparotomy, because the previous midline incisions 
usually did not involve the umbilicus, keeping the underlying region free from adhesion. Then, the abdominal cavity is 
examined to find adequate space for working ports. If there is not enough space for safe port insertion, the 
transumbilical incision can be elongated to permit specimen extraction, and adhesiolysis is performed under direct 
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vision. Once a camera port and one or two working ports are inserted, adhesiolysis can be performed after the creation 
of a pneumoperitoneum, which elevates the abdominal wall to provide a better dissection plane on laparoscopy. After a 
carbon dioxide pneumoperitoneum was created at 8 mm Hg, four operating ports and a Nathanson liver retractor (Cook 
Japan, Tokyo, Japan) were placed. Lymph node dissection was carried out using ultrasonically activated coagulating 
shears (SonoSurg®; Olympus, Tokyo, Japan), and the stomach was resected using an endoscopic linear stapler. 
Intracorporeal reconstruction was then carried out by either the Billroth-I [12] or Roux-en-Y method [13]. Radical 
lymphadenectomy, which was defined as D2 or D1+ lymph node dissection, was performed in both groups [11,14]. The 
extent of lymphadenectomy was in accordance with the Japanese Gastric Cancer Treatment Guidelines 2010 (ver. 3) 
[15] and the Japanese Classification of Gastric Carcinoma (3rd English edition) [16]. Postoperative complications, such 
as pneumonia, pleural effusion, atelectasis, cardiac events (myocardial infarction, heart failure and arrhythmias), 
anastomotic leakage, anastomotic stenosis, small bowel obstruction, diarrhea and wound infection, were defined as 
grade 2 or higher adverse events according to the National Cancer Institute Common Terminology Criteria for Adverse 
Events (NCI-CTCAE), version 4.0, that occurred within 30 days after the operation.  
 The statistical analysis was performed using the JMP 9 software program (SAS institute, Cary, NC, USA). 
The chi-square test was used to compare categorical datasets, and the unpaired t-test was used to compare the age and 
BMI of patients. Nonparametric datasets for variables such as the intraoperative blood loss, length of the operation, 
postoperative hospital stay and number of retrieved lymph nodes were compared using the Wilcoxon signed-rank test. P 




The demographic characteristics of the 22 patients who had undergone PUAS (LG-PUAS) are shown in Table 1. All 22 
patients had undergone PUAS one time. The clinical characteristics of the LG-PUAS group (n=22) and the control 
group (n=66) are shown in Table 2. The two groups were well matched, and there were no statistically significant 






The short-term surgical outcomes are shown in Table 3. The intraoperative factors were similar between the two groups. 
There was one open conversion in each group. One patient (4.5%) in the LG-PUAS group who had previously received 
a laparoscopic right hemicolectomy was converted to open surgery because of a spleen laceration during laparoscopic 
total gastrectomy, which was considered to be unrelated to the previous surgery, while bleeding from the splenic vein 
caused open conversion during laparoscopic distal gastrectomy in a patient in the control group. There were no cases 
that needed true additional port insertion that required an additional incision. However, one case following open right 
hemicolectomy (case #22) required 12 mm port insertion in advance of the insertion of the subxiphoid Nathanson 
retractor. In that case, after the adhesiolysis of the abdominal wall was finished, the subxiphoid port was changed to a 
Nathanson retractor. There were no differences between the groups in the proportion of patients who were 
intraoperatively converted to open surgery (4.5% vs 1.5%, P = 0.4088), the intraoperative blood loss (60 g vs 90 g, P = 
0.5119), the length of the operation (322 min vs 316 min, P = 0.6299) or the number of retrieved lymph nodes (42 vs 40, 
P = 0.3855). The postoperative morbidity (13.6% vs 10.6%, P = 0.6981) and mortality (0% vs 0%) were also similar. 
The postoperative complications (≥Grade 2) are summarized in Table 3. Small bowel obstruction did not occur in this 
study cohort, and PUAS was not associated with any specific complication. The median postoperative hospital stay was 
also similar in both groups (13.5 days vs 13.0 days, P = 0.8088).  
 
Comparison to OG 
During the same study period, 23 OG for patients with a history of PUAS (OG-PUAS) were performed. Of these 23 
patients, 22 patients had undergone PUAS one time and one patient had undergone PUAS twice (distal gastrectomy and 
cholecystectomy). The demographic characteristics of the 23 patients are summarized in Table 4. Due to the extension 
of our indications for LG, 21 (91%) out of 23 OG-PUAS procedures were performed before April 2009, when LG was 
indicated for more advanced disease. Thus, significantly more cases of advanced disease were treated by open surgery 
in the earlier period. When compared to OG-PUAS, LG-PUAS was associated with significantly less blood loss and an 




To our knowledge, this is the first comparative study to assess the feasibility of LG in patients who had undergone 
PUAS. Since only one case series investigating the feasibility of laparoscopy-assisted gastrectomy after open upper 
abdominal surgery has been reported [17], we believe that our results provide new evidence supporting the safety of LG 
in patients who have undergone PUAS. 
 In the early laparoscopic era [18], previous abdominal surgery was considered to be a contraindication for 
laparoscopic surgery, but it is no longer regarded to be an “absolute contraindication”. In fact, laparoscopic colorectal 
surgery, which is more widely performed throughout the world than LG, has been reported to be a safe and 
oncologically reliable procedure, despite a slightly higher [19,20] or similar [21] conversion rate in patients who have 
undergone PUAS. Our results demonstrate that LG is non-inferior to open surgery in terms of both safety and adequate 
lymph node retrieval in patients who have undergone PUAS. The number of harvested lymph nodes (42 in the PUAS 
group) was considerably higher than that reported previously (32.8 in patients who underwent open upper abdominal 
surgery in an earlier study) [17]. Our findings suggest that LG can be performed without any drawback, even in patients 
who have undergone PUAS. 
Technically, the hardest part of LG after PUAS was insertion of the first three trocars. However, 
transumbilical insertion of the first trocar by the open method is relatively easy, because the previous midline incisions 
usually do not involve the umbilicus. Then, the abdominal cavity can be examined to find adequate space for working 
ports. If there is not enough space for safe port insertion, the transumbilical incision can be elongated to permit 
specimen extraction, and adhesiolysis is performed under direct vision. Once a camera port and one or two working 
ports are inserted, adhesiolysis can be performed after the creation of a pneumoperitoneum, which elevates the 
abdominal wall to provide a better dissection plane on laparoscopy.  
Laparoscopic PUAS may cause less adhesion compared to open PUAS, and the initial placement of the 
trocars is sometimes easier in the laparoscopic PUAS group than in the open PUAS group. However, the difficulty of 
LG after PUAS also depends on the degree of the adhesions in the previously targeted area. Therefore, both 
laparoscopic and open PUAS were included in this analysis.  Indeed, previous gastrectomy usually causes considerable 
adhesion around the previous anastomosis and suture line at the lesser curvature, but the difficulty of adhesiolysis 
depends not on the type of PUAS, but on degree of adhesion in individual cases. In our study, laparoscopic proximal 
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gastrectomy after distal pancreatectomy (case #8) took more time with more intraoperative blood loss than the average 
operation time and intraoperative blood loss of the four cases of laparoscopic completion gastrectomy (data not shown). 
Hence, completion gastrectomy was also included in this analysis.    
 Our study had several important limitations. First, it was retrospective, and we cannot rule out potential 
selection bias in the matched-pair analysis. Our indications for LG were gradually extended during the study period in 
parallel to the refinement of our laparoscopic technique. Therefore, in the early part of the study, relatively 
“straightforward” cases underwent LG, whereas more “complicated” cases were included in the latter part. Thus, 
“not-yet-improved” LG in the earlier period might have offset the potential drawbacks in more challenging cases in the 
later period. However, our results regarding the postoperative morbidity, length of the operation and lymph node yield 
were not at all inferior to those of previous studies [5,17], especially considering that 50% of the patients underwent 
total gastrectomy. With regard to the oncological feasibility, long-term outcomes are not yet available. However, given 
that the number of retrieved lymph nodes is a surrogate marker of oncological surgical quality [22], LG appears to be an 
oncologically feasible procedure after PUAS. In the patients who had undergone PUAS, we did not have access to 
information on the specific indications for LG. Whether LG is indicated in individual patients should be based on the 
results of physical examinations, clinical history, findings at previous operation(s) and the capabilities of the surgeons. 
 In conclusion, the safety and feasibility of LG in patients who had previously undergone PUAS were similar 
to those in patients without a history of upper abdominal surgery. Therefore, PUAS should not be regarded as a 
contraindication for LG.   
 
Conflict of interest statement 





1 Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. 
2 Nakajima T: Gastric cancer treatment guidelines in japan. Gastric Cancer 2002;5:1-5. 
3 Van Cutsem E, Van de Velde C, Roth A, Lordick F, Köhne CH, Cascinu S, et al: Expert opinion on 
management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the european organisation for 
research and treatment of cancer (EORTC)-gastrointestinal cancer group. Eur J Cancer 2008;44:182-194. 
4 Katai H, Sasako M, Fukuda H, Nakamura K, Hiki N, Saka M, et al: Safety and feasibility of 
laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: A 
multicenter phase II trial (JCOG 0703). Gastric Cancer 2010;13:238-244. 
5 Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, et al: Laparoscopic versus open 
subtotal gastrectomy for distal gastric cancer: Five-year results of a randomized prospective trial. Ann Surg 
2005;241:232-237. 
6 Lee SW, Nomura E, Bouras G, Tokuhara T, Tsunemi S, Tanigawa N: Long-term oncologic outcomes from 
laparoscopic gastrectomy for gastric cancer: A single-center experience of 601 consecutive resections. J Am Coll Surg 
2010;211:33-40. 
7 Park DJ, Han SU, Hyung WJ, Kim MC, Kim W, Ryu SY, et al: Long-term outcomes after 
laparoscopy-assisted gastrectomy for advanced gastric cancer: A large-scale multicenter retrospective study. Surg 
Endosc 2011 
8 Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N, Japanese Laparoscopic Surgery Study Group: A 
multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in japan. Ann Surg 
2007;245:68-72. 
9 UICC International Union Against Cancer: TNM classification of malignant tumours, ed 7th. New York, 
Wiley-Blackwell, 2009. 
10 Tanigawa N, Lee SW, Kimura T, Mori T, Uyama I, Nomura E, et al: The endoscopic surgical skill 
qualification system for gastric surgery in japan. Asian J Endosc Surg 2011;4:112-115. 
11 Obama K, Okabe H, Hosogi H, Tanaka E, Itami A, Sakai Y: Feasibility of laparoscopic gastrectomy with 




12 Kanaya S, Gomi T, Momoi H, Tamaki N, Isobe H, Katayama T, et al: Delta-shaped anastomosis in totally 
laparoscopic billroth i gastrectomy: New technique of intraabdominal gastroduodenostomy. J Am Coll Surg 
2002;195:284-287. 
13 Okabe H, Obama K, Tanaka E, Nomura A, Kawamura J, Nagayama S, et al: Intracorporeal esophagojejunal 
anastomosis after laparoscopic total gastrectomy for patients with gastric cancer. Surg Endosc 2009;23:2167-2171. 
14 Okabe H, Obama K, Kan T, Tanaka E, Itami A, Sakai Y: Medial approach for laparoscopic total gastrectomy 
with splenic lymph node dissection. J Am Coll Surg 2010;211:e1-6. 
15 Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric 
Cancer 2011;14:113-123. 
16 Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd english edition. 
Gastric Cancer 2011;14:101-112. 
17 Tokunaga M, Hiki N, Fukunaga T, Nunobe S, Ohyama S, Yamaguchi T: Laparoscopy-assisted gastrectomy 
for patients with earlier upper abdominal open surgery. Surg Laparosc Endosc Percutan Tech 2010;20:16-19. 
18 Curet MJ: Special problems in laparoscopic surgery. Previous abdominal surgery, obesity, and pregnancy. 
Surg Clin North Am 2000;80:1093-1110. 
19 Arteaga González I, Martín Malagón A, López-Tomassetti Fernández EM, Arranz Durán J, Díaz Luis H, 
Carrillo Pallares A: Impact of previous abdominal surgery on colorectal laparoscopy results: A comparative clinical 
study. Surg Laparosc Endosc Percutan Tech 2006;16:8-11. 
20 Barleben A, Gandhi D, Nguyen XM, Che F, Nguyen NT, Mills S, et al: Is laparoscopic colon surgery 
appropriate in patients who have had previous abdominal surgery? Am Surg 2009;75:1015-1019. 
21 Law WL, Lee YM, Chu KW: Previous abdominal operations do not affect the outcomes of laparoscopic 
colorectal surgery. Surg Endosc 2005;19:326-330. 
22 Lee JH, Ryu KW, Park SR, Kim CG, Kook MC, Nam BH, et al: Learning curve for total gastrectomy with D2 
lymph node dissection: Cumulative sum analysis for qualified surgery. Ann Surg Oncol 2006;13:1175-1181. 
10 
 
Table 1. Demographics of patients who had undergone previous upper abdominal surgery 
Case Age Sex Previous upper abdominal surgery (PUAS) BMI cStage Type of LG Lymphadenectomy 
1 56 M cholecystectomy 22.0 IA DG D2 
2 69 M laparoscopic cholecystectomy 29.4 IA DG D1+ 
3 80 M laparoscopic right hemicolectomy 20.5 IA TG D1+ 
4 68 M PPG 20.7 IA CG D2 
5 74  F laparoscopic gastrojejunostomy 17.7 IIIA DG D2 
6 65 F partial gastrectomy 20.2 IA PPG D1+ 
7 77 M laparoscopic right hemicolectomy 19.0 IA TG D1+ 
8 63 F distal pancreatectomy 18.3 IA PG D1+ 
9 74 M DG (Billroth-II) 18.4 IA CG D1+ 
10 82 F transabdominal left nephrectomy 24.0 IB TG D1+ 
11 59 F laparoscopic cholecystectomy 20.4 IA DG D1+ 
12 54 M DG (Billroth-II) + cholecystectomy 17.2 IA CG D1+ 
13 74 F ileocecal resection 21.3 IA DG D2 
14 67 M cholecystectomy 25.4 IA PG D1+ 
15 77 M partial hepatectomy (segment 8) + cholecystectomy 23.6 IB TG D1+ 
16 50 M laparoscopic gastrojejunostomy 25.9 IIB DG D2 
17 64 F radical hysterectomy + para-aortic node dissection 18.6 IA DG D1+ 
18 58 M DG (Billroth-II) 18.9 IB CG D1+ 
19 72 M laparoscopic cholecystectomy 25.3 IA DG D1+ 
20 72 M cholecystectomy 23.0 IA DG D1+ 
21 73 M aortofemoral bypass 24.6 IA PG D1+ 
22 72 M right hemicolecomy 20.0 IA DG D1+ 
Abbreviations; DG: Distal gastrectomy, TG: Total gastrectomy, PG: Proximal gastrectomy, PPG: Pylorus-preserving 
gastrectomy, CG: Completion gastrectomy  
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 Table2. Patient characteristics and data on operation. 
Variables  PUAS (n=22) Control (n=66) P value 
Age mean 68.2 (50-82) 67.2 (50-89) NS (0.6652) 
Sex (M:F) 15:7 41:25 NS (0.6088) 
BMI mean (kg/m2) 21.6 21.6 NS (0.9974) 
cStage I / II / III / IV 20 / 1 / 1 / 0 63 / 2 / 1/ 0 NS (0.6657) 


















       Table 3. Perioperative outcomes 
  PUAS (n=22) Control (n=66) P value 
Open conversion  1 (4.5%) 1 (1.5%) P=0.4088 
Postoperative complications (≥CTCAE Grade 2) 3 (13.6%) 7 (10.6%) P=0.6981 
 Peripancreatic abscess 1 2  
 Intra-abdominal abscess 1 1  
 Pneumonia 1   
 Delayed gastric emptying  2  
 Ileum perforation   1  
 Angina pectoris  1  
Mortality within 30 days  0 (0%) 0 (0%) NA 
Blood loss (g) (median) 60 (0 – 900) 90 (0 – 3600) P=0.5119 
Length of operation 
(min) 
(median) 322 (200 - 476) 316 (204 - 472) P=0.6299 
Hospital stay (days) (median) 13.5 (8 – 35) 13.0 (8 – 85) P=0.8088 




Table 4. Comparison to open gastrectomy 
Variables  LG-PUAS (n=22) OG-PUAS (n=23) P value 
Age mean 68.2 (50-82) 69.5 (48-87) 0.6502 
Sex (M:F) 15:7 16:7 0.9202 
BMI mean (kg/m2) 21.6 21.8 0.8433 
cStage I / II / III / IV 20 / 1 / 1 / 0 13 / 5/ 5/ 0 0.0334 














Lymphadenectomy D1+ / D2 17 / 5 10 / 13 0.0207 
Postoperative complications (≥CTCAE Grade 2) 3 (13.6%) 3 (10.6%) 0.9534 
 Peripancreatic abscess 1 1  
 Intra-abdominal abscess 1 1  
 Pneumonia 1   
 Anastomotic stricture  2  
Mortality  < 30 days  0 (0%) 0 (0%) NA 
Blood loss (g) median 60 (0 – 900) 590 (190 – 1530) <0.0001 
Operative time (min) median 322 (200 - 476) 275(194 - 536) 0.1369 
Hospital stay (days) median 13.5 (8 – 35) 15.0 (11 – 78) 0.1005 
Lymph node yield median 42 (6 – 85) 27 (2 – 87) 0.1397 
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